China BioPharma Ltd. Signs Letter of Intent to Acquire Hainan CITIC Biopharmaceutical, China's Largest Vaccine Distributor.

ISELIN, N.J. -- Techedge Inc. (OTCBB:TEDG) announced that China BioPharma's subsidiary Zhejiang Tianyuan Biotech Co., has signed a letter of intent to acquire Hainan CITIC Biopharmaceutical Development Co. ("Hainan CITIC").

Under the agreement Zhejiang Tianyuan Biotech Co. would acquire over 90% interest in Hainan CITIC Biopharmaceutical Development Co., with the remaining interest being owned by China CDC (China's Center for Disease Control).

Hainan CITIC is the largest vaccine distributor in China, with an extensive customer network in most major cities within the country. The company has established its 'cold chain' for distribution logistics for most major parts of China. The Company was the distributor for major international vaccine suppliers, such as GSK and Chiron Vaccines.

"We are very excited about this acquisition," Dr. Jean-Denis Shu, CEO of China Biopharma Limited stated, "this acquisition will bring us an effective platform and strong market position for promoting our vaccines and other related biopharmaceutical products in China."

About Techedge, Inc.

Techedge, Inc. is a fast growing developer, producer, and distributor of biopharmaceutical products in China. It has wholly owned subsidiary, China Biopharma Limited and owns the majority interest of Zhejiang Tianyuan Biotech Co., Ltd ("ZTB"). The Company's current products consist of human vaccines against influenza, epidemic hemorrhagic fever (HFV), and Japanese Encephalitis (JEV) with high reputation and market shares among Chinese made vaccines. Through its investment and ownership of leading Chinese biopharmaceutical companies, the company plans to build the most efficient and most profitable biopharmaceutical company in China by introducing the most advanced technology, best product, and experienced management team. With a fast growing market, newly completed production facility, and several other new vaccines in the pipeline, it is expected to have a steady business growth. For more information, please visit its website at www.techedgeinc.net

FORWARD-LOOKING STATEMENT DISCLAIMER

Some of the statements made in this press release discuss future events and developments, including our future business strategy and our ability to generate revenue, income and cash flow, and should be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These "forward-looking" statements can generally be identified by words such as "expect," "anticipate," "believe," "estimate," "intend," "plan," and similar expressions. These statements involve a high degree of risk and uncertainty that exists in the Company's operations and business environment and are subject to change based on various factors that could cause actual Company results, performance, plans, goals and objectives to differ materially from those contemplated or implied in these forward-looking statements. Actual results may be different from anticipated results for a number of reasons, including the Company's new and uncertain business model, uncertainty regarding acceptance of the Company's products and services and the Company's limited operating history.